Home > Boards > US Listed > Biotechs >

Acadia Pharmaceuticals Inc. (ACAD)

Add ACAD Price Alert      Hide Sticky   Hide Intro
Search This Board:
Last Post: 2/5/2016 2:43:44 AM - Followers: 112 - Board type: Free - Posts Today: 1

ACADIA Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. Its developing products include Pimavanserin for the treatment of Parkinson's disease psychosis in Phase III trials; Pimavanserin as a co-therapy for schizophrenia in Phase II trials; ACP-104 for the treatment of schizophrenia in Phase IIb clinical trials; Pimavanserin for sleep maintenance insomnia in Phase II trials; AGN-XX and AGN-YY for neuropathic pain in Phase II trials; and AC-262271 for glaucoma in Phase I trials. The company's developing pipeline also consists of ACP-105 for endocrine indications in IND-track development stage; ACP-106 for neuropsychiatry and sleep indications in IND-track development stage; Serotonin program for neuropsychiatry and sleep indications in preclinical stage; pro-cognitive antipsychotic (PCAP) program for schizophrenia in preclinical stage; Muscarinic program for neuropsychiatry and other indications in preclinical stage; and Cannabinoid CB1 program for obesity in preclinical stage. The company has collaboration agreements with Allergan, Inc. to discover, develop, and commercialize new therapeutics for ophthalmic indications, selective muscarinic drugs for the treatment of glaucoma, and new therapeutics for neuropathic pain. ACADIA Pharmaceuticals, formerly known as Receptor Technologies, Inc., was founded in 1993. The company is headquartered in San Diego, California.


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ACAD News: ACADIA Pharmaceuticals to Present at the LEERINK Partners 5th Annual Global Healthcare Conference on February 10, 2016 02/03/2016 09:00:00 AM
ACAD News: ACADIA Pharmaceuticals Announces FDA Advisory Committee Meeting to Review NUPLAZID™ (Pimavanserin) for the Treatment of Par... 01/29/2016 04:05:00 PM
ACAD News: Amended Statement of Ownership (sc 13g/a) 01/25/2016 01:48:36 PM
ACAD News: ACADIA Pharmaceuticals Appoints James (Randy) R. Owen, M.D., as Senior Vice President, Clinical Development & Chief Medical O... 01/25/2016 09:00:00 AM
ACAD News: Current Report Filing (8-k) 01/12/2016 04:31:26 PM
#1799   anyone have an idea what caused the nice jloerke 02/05/16 02:43:44 AM
#1798   bought in at $19.10 and $18.11, looks like jloerke 02/04/16 08:47:20 PM
#1797   good for u! be very interesting harry crumb 02/04/16 01:41:47 PM
#1796   Bought a few. Hoping bottom is in and Jumpinjackas 02/04/16 09:50:32 AM
#1795   flippers made some hefty profits today! $$$ harry crumb 02/03/16 04:36:16 PM
#1794   gapped to 1$ split, nice harry crumb 02/03/16 11:39:47 AM
#1793   fill the gap, flip in/out $$$ harry crumb 02/03/16 10:50:19 AM
#1792   Did they close the offering? Jumpinjackas 02/03/16 10:14:52 AM
#1791   short term probably down more before up.... Chance 02/03/16 04:50:50 AM
#1790   the entire bio industry/sector has been in a harry crumb 02/02/16 07:04:57 PM
#1789   Lol. You will be saying that again. Jumpinjackas 02/02/16 02:32:01 PM
#1788   LOL. The biotech space is littered with nowlurking 02/02/16 12:27:47 PM
#1787   wow what a buying oppertunity! harry crumb 02/02/16 12:04:32 PM
#1786   I bought most of these mid/big pharmas years 2014shelby 01/29/16 08:42:17 PM
#1785   very nice after hours trading with acad, next harry crumb 01/29/16 08:39:16 PM
#1784   its retail groupies an hedge, its a no harry crumb 01/29/16 08:35:44 PM
#1783   Who's shorting and when do you expect the 2014shelby 01/29/16 08:17:41 PM
#1782   its being shorted! just like all bio's when harry crumb 01/29/16 07:52:16 PM
#1781   Questions... Hence the question mark. Jumpinjackas 01/29/16 04:49:49 PM
#1780   Was that a statement or a question? north40000 01/29/16 04:35:41 PM
#1779   You have no clue as to who is Jumpinjackas 01/29/16 04:13:29 PM
#1778 Jumpinjackas 01/29/16 03:53:12 PM
#1777   all the way back! thats power, this is harry crumb 01/29/16 03:32:47 PM
#1776   Bios have recovered.. Jumpinjackas 01/29/16 01:17:22 PM
#1775   Yeah. Baker boys were here when the phase Jumpinjackas 01/29/16 01:16:36 PM
#1774   acad needs to pr something, the shorts are harry crumb 01/28/16 02:10:29 PM
#1773   acad wouldnt be getting ready for production an harry crumb 01/27/16 04:10:05 PM
#1772   i doubt it, typical short attack before the harry crumb 01/27/16 04:08:21 PM
#1771   Fda will deny this one. Watch. Jumpinjackas 01/27/16 08:19:49 AM
#1770   decent recovery, good day for flippers who bought harry crumb 01/26/16 04:05:56 PM
#1769   patience friend. they serve on the board an harry crumb 01/26/16 12:51:43 PM
#1768   What are the Bakers doing for ACAD if anything? 2014shelby 01/26/16 06:57:51 AM
#1767   yeah, another new md appointed. all good happenings harry crumb 01/25/16 11:32:33 AM
#1766   During market frenzy at ACAD 2014shelby 01/25/16 11:24:14 AM
#1765   premarket frenzy! harry crumb 01/22/16 09:16:29 AM
#1764   nice buying/covering today. play the gaps people. harry crumb 01/20/16 07:58:16 PM
#1763   the shorting frenzy started in the 40's, they harry crumb 01/19/16 04:51:34 PM
#1762   Another trial..I doubt it. They submitted NDA(drug application)..waiting christjamin 01/17/16 07:09:10 PM
#1761   The trial was not initially designed for approval. Jumpinjackas 01/17/16 06:22:24 PM
#1760   Instead, going it alone is better proposition for christjamin 01/17/16 06:05:20 PM
#1759   Based on the last raised funding, which has Jumpinjackas 01/17/16 10:20:12 AM
#1758   Better to appear as a fool then to Jumpinjackas 01/17/16 10:14:43 AM
#1757   You should read what you post. If placebo Jumpinjackas 01/17/16 10:13:36 AM
#1756 christjamin 01/16/16 09:28:51 PM
#1755 christjamin 01/16/16 09:28:45 PM
#1754 christjamin 01/16/16 09:24:02 PM
#1753   On 9/1/2009, indeed pimavanserin failed. No doubt. No christjamin 01/16/16 09:22:26 PM
#1752   negative! the drug never failed. due yur dd harry crumb 01/16/16 09:15:27 PM
#1751   Hasn't the drug failed previously? Why CEO resigned christjamin 01/16/16 08:28:43 PM
#1750   doesnt compare to this company. bb boys wouldnt harry crumb 01/16/16 07:54:44 PM